Correspondence
To the Editor: Ma2 antibody-mediated encephalitis is a rare type of paraneoplastic neurological syndrome (PNS) present with various clinical symptoms. Lung or testicular germ-cell malignancies are the most commonly associated tumors. [1] Here, we reported a patient with a Ma2 antibody-mediated encephalitis related to ileal lymphoma.
A 62-year-old male with a history of hypertension and diabetes mellitus presented with 6 months of mental and behavior change. He had memory loss and visual hallucinations since September 2013. The patient gained 12.5 kg of bodyweight increase due to increased appetite and was diagnosed as bulimia nervosa at a local hospital. He also stated dizziness, unstable walking and diplopia with ptosis of bilateral eyelids. He felt sleepy and drowsy during daytime but sleepless at night. He also experienced urinary incontinence occasionally. On admission, the patient was alert. The mini-mental state examination was 18/30, indicating moderate impairment of memory. The patient had vertical gaze paresis, unable to look upward and downward with horizontal nystagmus. His muscle power and muscle tone were normal with diminished tendon reflexes. He had unstable gait and could not walk in a straight line. Anti-Ma2 encephalitis differs from typical paraneoplastic limbic encephalitis for most patients developed combination of the limbic system, diencephalon or brainstem encephalitis. Hypothalamus and pituitary gland could even be involved. [2] It was reported in young patients with testicular cancer or tumors of lung and breast. [3] We described the clinical and pathological findings in a patient with limbic encephalitis associated with submucosal follicular lymphoma of the ileum. It broadens the spectrum of tumor associated with this rare PNS. The clinical manifestation and neuroimaging of this patient suggested a combined limbic, diencephalic and brainstem lesions. In fact, only 26% of the patients had classical limbic encephalitis in the literature. Excessive daytime sleepiness, as presented, in this case, affected 32% of the patients, sometimes with narcolepsy cataplexy. [1] After receiving oncological treatment and immunotherapy, including steroids, IVIg and plasma exchange, some patients have neurological improvement. But nearly half of the patients deteriorated after treatment.
Anti-Ma2-associated encephalitis has a unique clinical presentation and should not be overlooked considering its remarkable involvement of the limbic system, diencephalon and brainstem. This disorder should be suspected in patients with subacute involvement of one or more of these three brain regions and CSF abnormalities suggesting an inflammatory process.
